Coculture of blood forms of Trypanosoma cruzi with human peripheral blood mononuclear cells stimulated with anti-CD22 and anti-CD23 monoclonal antibodies, i.e., via an antigen-independent pathway of Tlymphocyte activation, resulted in marked immunosuppression compared with that in parallel cultures in which parasites were absent. This effect was evidenced by a decreased lymphoproliferative capacity, a significant reduction in the proportion of cells expressing interleukin-2 receptors, and a significant diminution in the cell surface density of this receptor.
Chagas' disease, which is caused by the protozoan Trypanosoma cruzi, affects millions of people in South and Central America, and cases have been occasionally reported in North America (7, 13, 17, 21) . The acute phase of both the experimental and human forms of the disease is accompanied by immunosuppression (5, 6, 8, 9, 14-16, 18, 19 ; J. C. Voltarelli, E. A. Donadi, and R. P. Falcao, Letter, Trans. R. Soc. Trop. Med. Hyg. 81: [169] [170] 1987) , which is thought to reduce resistance to the establishment and dissemination of the organism in the host. We have previously shown that the presence of T. cruzi inhibits lymphoproliferation and the expression of interleukin-2 (IL-2) receptors (IL-2R) induced by either phytohemagglutinin (PHA) or anti-CD3 monoclonal antibodies (2, 10, 11) . Meuer and co-workers (12) uncovered a new, antigen-independent pathway of human T lymphocyte activation triggered by anti-CD22 plus anti-CD23 monoclonal antibodies (formerly designated anti-T112 and anti-T113, respectively) which, in contrast to PHA or anti-CD3, activate human lymphocytes in a macrophage-independent manner (3). To study whether T. cruzi could also affect lymphoproliferation initiated by this antigen-and macrophage-independent pathway, we studied the effects of the parasite on proliferation and IL-2R expression by human lymphocytes stimulated with the anti-CD2 antibodies.
T. cruzi trypomastigotes (Tulahuen isolate) were purified from the blood of Crl-CD1(ICR) Swiss mice (Charles River Laboratories, Portage, Mich.) that were infected subcutaneously 9 to 11 days previously with 5 x 105 organisms. The parasites were purified by centrifugation over Ficoll-Hypaque (400 x g, 20°C, 45 min), followed by diethylaminoethylcellulose chromatography (4, 20) . After the parasites were washed with serum-free RPMI 1640 medium (GIBCO Laboratories, Grand Island, N.Y.) containing 100 IU of penicillin and 100 ,ug of streptomycin per ml, they were suspended in the same medium supplemented with 5% heat-inactivated (56°C, 20 min) fetal bovine serum (referred to as complete medium). The suspension consisted of 100% trypomastigotes (>99% viable).
Normal human peripheral blood mononuclear cells (PBMCs) were purified by centrifugation over a mixture of Ficoll-Hypaque. After three washings with serum-free medium, the cells were suspended at the desired concentration in complete medium. Cell viability was >99%.
PHA (Table 1) . Under all of these stimulatory conditions, the extent of the recorded suppression was greater as the parasite concentration was increased.
We also measured the expression of IL-2R by anti-CD2- stimulated PBMCs to establish whether this critical event in lymphocyte activation was also modulated by T. cruzi, as is the case with PHA-stimulated cells (2) . Parallel experiments performed with PHA and anti-CD2 indicated that, in both cases, the percentage of cells expressing IL-2R was significantly reduced in the presence of T. cruzi (Fig. 1) . Further (1) . We have also ruled out increased PBMC death, mitogen absorption, and consumption of essential medium nutrients as possible causes of the suppressive effects of T. cruzi (1, 2 
